| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q9EPH8 | Polyadenylate-binding protein 1; PABP-1; Poly(A)-binding protein 1; | Pabpc1; Pabp1; | NP_599180.1; | 636 | rat |
| P13589 | Pituitary adenylate cyclase-activating polypeptide; PACAP; [Cleaved into: PACAP-related peptide (PRP-48); Pituitary adenylate cyclase-activating polypeptide 27 (PACAP-27) (PACAP27); Pituitary adenylate cyclase-activating polypeptide 38 (PACAP-38) (PACAP38癷?癸 | Adcyap1; | NP_058685.1;XP_006245734.1;XP_006245735.1;XP_006245736.1;XP_008765640.1;XP_008765641.1; | 175 | rat |
| Q9Z0W5 | Protein kinase C and casein kinase substrate in neurons protein 1; Dynamin proline-rich domain-interacting protein; Dynamin PRD-interacting protein; Synaptic, dynamin-associated protein I; Syndapin-1; Syndapin-I; SdpI; | Pacsin1; | NP_058990.1; | 441 | rat |
| Q9QY17 | Protein kinase C and casein kinase substrate in neurons 2 protein; Synaptic dynamin-associated protein II; Syndapin-2; Syndapin-II; SdpII; | Pacsin2; | NP_570096.2;XP_006242112.1;XP_006242113.1;XP_006242114.1;XP_006242115.1;XP_006242117.1;XP_006242119.1;XP_006242120.1;XP_006242121.1;XP_006242122.1; | 488 | rat |
| P32215 | Pituitary adenylate cyclase-activating polypeptide type I receptor; PACAP type I receptor; PACAP-R-1; PACAP-R1; | Adcyap1r1; | NP_001257508.1;NP_001257509.1;NP_001257510.1;NP_001257511.1;NP_001257512.1;NP_598195.1;XP_008761092.1; | 523 | rat |
| O88588 | Phosphofurin acidic cluster sorting protein 1; PACS-1; | Pacs1; | NP_599233.1; | 961 | rat |
| O88806 | Protein-arginine deiminase type-1; EC 3.5.3.15; PAD-R11; Peptidylarginine deiminase I; Protein-arginine deiminase type I; | Padi1; Pdi1; | NP_062205.1; | 662 | rat |
| P20717 | Protein-arginine deiminase type-2; EC 3.5.3.15; Peptidylarginine deiminase II; Protein-arginine deiminase type II; | Padi2; Pdi Pdi2; | NP_058922.1; | 665 | rat |
| P70708 | Protein-arginine deiminase type-3; EC 3.5.3.15; Peptidylarginine deiminase III; Protein-arginine deiminase type III; | Padi3; Pdi3; | NP_058926.1; | 664 | rat |
| O88807 | Protein-arginine deiminase type-4; EC 3.5.3.15; PAD-R4; Peptidylarginine deiminase IV; Peptidylarginine deiminase type alpha; Protein-arginine deiminase type IV; | Padi4; Pdi4; | NP_058923.1; | 666 | rat |
| Q6RIA2 | PCNA-associated factor; HCV NS5A-transactivated protein 9 homolog; PCNA-associated factor of 15 kDa; PAF15; p15PAF; | Paf; Ns5atp9; | NP_958821.1; | 110 | rat |
| Q4V886 | RNA polymerase II-associated factor 1 homolog; | Paf1; | NP_001020069.1; | 535 | rat |
| P83006 | Platelet-activating factor acetylhydrolase 2, cytoplasmic; EC 3.1.1.47; Serine-dependent phospholipase A2; SD-PLA2; | Pafah2; | NP_808793.1;XP_006239189.1; | 390 | rat |
| Q675A5 | Group XV phospholipase A2; EC 2.3.1.-; 1-O-acylceramide synthase; ACS; LCAT-like lysophospholipase; LLPL; Lysophospholipase 3; Lysosomal phospholipase A2; LPLA2; | Pla2g15; Lypla3; | NP_001004277.1; | 413 | rat |
| Q5M865 | PAXIP1-associated glutamate-rich protein 1; PAXIP1-associated protein 1; PTIP-associated protein 1; | PAGR1; | NP_001013923.1; | 253 | rat |
| P06303 | Pancreatic prohormone; Pancreatic polypeptide; PP; [Cleaved into: Pancreatic hormone (PH); C-terminal peptide]; | Ppy; | NP_036758.1; | 98 | rat |
| P57093 | Phytanoyl-CoA dioxygenase, peroxisomal; EC 1.14.11.18; Phytanic acid oxidase; Phytanoyl-CoA alpha-hydroxylase; PhyH; | Phyh; | NP_446126.1; | 338 | rat |
| P20961 | Plasminogen activator inhibitor 1; PAI; PAI-1; Endothelial plasminogen activator inhibitor; Serpin E1; | Serpine1; Pai1 Planh1; | NP_036752.1; | 402 | rat |
| P29524 | Plasminogen activator inhibitor 2 type A; PAI-2; PAI2A; Serpin B2; | Serpinb2; Pai2 Planh2; | NP_067728.1;XP_006249701.1;XP_008767717.1; | 416 | rat |
| Q6AXZ0 | Polyadenylate-binding protein-interacting protein 2; PABP-interacting protein 2; PAIP-2; Poly(A)-binding protein-interacting protein 2; | Paip2; | NP_001014170.1;XP_008770266.1;XP_008770268.1;XP_008770269.1;XP_008770270.1;XP_008770271.1; | 124 | rat |
